B
oots has revealed a soar in gross sales over the previous quarter because it was buoyed by surging demand for skincare merchandise.
It got here as US mum or dad agency Walgreens Boots Alliance (WBA) forecast a decrease than beforehand anticipated revenue for 2024 because it was impacted by the sharp discount in Covid-19-related vaccines and remedy.
In the UK, the pharmacy operator stated retail gross sales elevated by 11.7% year-on-year over the three months to August 31. It meant gross sales had been 12.5% increased over the 12 months to August.
The firm stated it benefited from increased footfall throughout its massive metropolis centre retailers, buying centres and journey shops.
We have nice plans for the 12 months forward together with our new magnificence retailer in Battersea, an extra extension of our magnificence class, growth of our on-line physician service and way more
It additionally stated it was supported by a soar in skincare gross sales, which grew “nearly 25%” over the most recent quarter.
Boots stated gross sales of own-label skincare had been up by “over a third” whereas its No7 model was up by round 20%.
It additionally reported a roughly 20% gross sales soar for its premium magnificence merchandise, highlighting robust demand for merchandise from The Ordinary and Drunk Elephant.
In the group’s healthcare division, it recorded a 9.9% enhance in pharmacy gross sales for the quarter.
Seb James , managing director of Boots UK and ROI, stated: “I am really encouraged to see continued strong performance as the work that we have done to expand our ranges, drive value and innovate in beauty seems to be resonating extremely well with customers.
“We have great plans for the year ahead including our new beauty store in Battersea , a further extension of our beauty category, expansion of our online doctor service and much more.
“I would like to thank the 52,000 people that make up the Boots business for the hard work and resilience that has made this possible.”
